Patent Expiry
OCUL: DEXTENZA: recorded patent 12144889 expiry
April 26, 2041 · DEXAMETHASONE. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- April 26, 2041
- Company
- OCULAR THERAPEUTIX, INC (OCUL)
- Drug
- DEXAMETHASONE
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
DEXTENZA: recorded patent 12144889 expiry
Orange Book application NDA208742, product 001, listed patent 12144889 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source
- Drug
- DEXAMETHASONE